References
- COUNCIL RECOMMENDATION of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02) Off J Eur U C. 151:7 - 10. (http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF). Accessed February 20 2013.
- Foltánová T et al., Orphan drugs used for the treatment in pediatric patients in the Slovak republic. Acta Fac. Pharm. Univ. Comen. 2012, Suppl VI:28 - 34. (http://www.degruyter.com/view/j/afpuc.2012.lix.issue-0/v10219-012-0001-0/v10219-012-0001-0.xml?format=INT) Accessed February 20 2013.
- Kovács L. et al. National Centers of Expertise and the European Reference Network for Rare Diseases. Acta Fac. Pharm. Univ. Comen. 2012, Suppl VII:15. (http://www.degruyter.com/view/j/afpuc.2012.vii.issue-0/v10219-011-0020-2/v10219-011-0020-2.xml?format=INT). Accessed February 20 2013.
- Vazna A et al. Mucopolysaccharidosis type I in 21 Czech and Slovak patients: mutation analysis suggests a functional importance of C-terminus of the IDUA protein. Am J Med Genet Part A, 2009, May;149A(5):965-74. (http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.32812/abstract;jsessionid=CBEB723E4292DD726D9E3C6D21B47C2D.d04t02). Accessed February 20 2013.